European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Viatris Healthcare GmbH, Troisdorf, Germany

Watch
Viatris Healthcare GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier is a comprehensive company details as a PDF and publications in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Complete Dossier
Entire company details along with publications bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans
Risk report
Viatris Healthcare GmbH
Risk Level Evaluation Source
Sanctioned (?)

Name

Viatris Healthcare GmbH
Mylan Healthcare GmbH
Abbott Arzneimittel GmbH
Solvay Arzneimittel GmbH

Identification

Ut
District Court of Siegburg HRB 15331
Ut
District Court of Hanover HRB 8196
EUID
DER3208.HRB15331

Address

Lütticher Str. 5, 53842 Troisdorf, Germany
Hannover, Germany

Corporate purpose

The manufacture and distribution of and trade in pharmaceuticals and pharmaceutical chemicals.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
1Managing Director
5Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Portfolio and Investments
2 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Pension provisions
Trademarks
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2006 to 2021
Profit & Loss
from 2006 to 2021
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

24 Aug 2026
Wordmark: “SEGVETU PLUS“
21 Aug 2026 via ROTTAPHARM I MADAUS GmbH also 09/02/2021
Shareholder: ROTTAPHARM I MADAUS GmbH
Year 2026 in Dpmam
81 trademark filings: ALFUZOSIN-DURA, Acardura, Air-Haler, Amiodura, Amlodipin dura, Azathiodura, Carbadura, Cefpodoxim dura, Contramig S, DOPADURA, DURA, DURAVITAL, Doxepin dura, Finadura, Finadura …
31 Jul 2026
No longer Managing Director: Rainer Weiß
18 May 2026
No longer Authorized signatory (ppa): Eiko Söhlke
19 Mar 2026
Wordmark: “IGICEP“
Year 2025 in Euipotm
4 wordmarks: BRUFEN 400, BRUFEN sirup, IGICEP, SEGVETU
5 Nov 2025
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · 16 Shareholdings (16 companies)
Year 2025 in Dpmam
12 trademark filings: ARMOLIPIB, ARMOLIPIL, DINUVE, FROBEN, Futuril, Johanniskraut-dura, Proanger, Trimobact, ZOANNE …
19 Aug 2025
Merger: Mylan dura GmbH
19 Aug 2025
The creditors of the legal entities involved in the merger shall, if, within six months of the date on ...
30 Dec 2024
Authorized signatory (ppa) (6)
17 Dec 2024
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020 · Shareholder (19 companies)
28 Nov 2024
Address · Sub­sidiary
25 Jul 2024
Authorized signatory (ppa): Andrea Ch. Herrmann
3 Jun 2024
Managing Director: Arun Narayan
31 Dec 2023 also 31/12/2022
Befreiender Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
23 Nov 2023
No longer Authorized signatory (ppa) (1)
25 Oct 2023
Wordmark: “Clift“
Year 2023 in Dpmam
2 wordmarks: ARMOLIPIB, DINUVE, FROBEN, Futuril, Lipimic, Lipomic, MULFINYA, Mavik, PROCORUM, Proanger, Sosegan, Trimobact, UDRIK, VIXARGIO, ZOANNE …
Year 2023 in Dpmam
17 trademark filings: Aktisan, DINUVE, FROBEN, Futuril, Lipimic, Lipomic, MULFINYA, Mavik, PROCORUM, Proanger, Sosegan, Trimobact, UDRIK, ZOANNE …
19 Jun 2023
Managing Director: Arun Narayan · No longer Managing Director: Jozef Belcik
19 Dec 2022
Authorized signatory (ppa): Sven Hartmann · No longer Authorized signatory (ppa) (1)
Year 2022 in Dpmam
7 trademark filings: Futuril, Lipimic, Lipomic, PROCORUM, Proanger, Sosegan, Trimobact
Year 2022 in Dpmam
5 trademark filings: Aktinorm, Aktisan, Futuril, GUMBARAL, Luzan
4 Nov 2022
Word figurative mark: “My Pancreas My Health Empower with Knowledge“
12 Aug 2022
Befreiender Konzernabschluss gem. § 292 HGB zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
5 Apr 2022
Share­holder agreement · Name: Viatris Healthcare GmbH
21 Mar 2022
Original document: “Gesellschaftsvertrag / Satzung / Statut“
18 Mar 2022 as Mylan Healthcare GmbH
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · Shareholder (25 companies)
8 Feb 2022 as Mylan Healthcare GmbH
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
31 Dec 2021
Exempting consolidated financial statements for the financial year from 01.01.2021 to 31.12.2021
5 Aug 2021 as Mylan Healthcare GmbH
No longer Authorized signatory (ppa): Mirko Ische
5 May 2021
Wordmark: “ELTHON“
23 Feb 2021 as Mylan Healthcare GmbH
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · 18 Shareholdings (18 companies)
2 Feb 2021 as Mylan Healthcare GmbH
Befreiender Konzernabschluss gem. § 291 HGB zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
18 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
17 Nov 2020
Original document: “Liste der Gesellschafter“
13 Nov 2020
Original document: “Liste der Gesellschafter“
11 Nov 2020
Original document: “Liste der Gesellschafter“
8 Sept 2020 as Mylan Healthcare GmbH
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · 19 Shareholdings (19 companies)
18 Aug 2020 as Mylan Healthcare GmbH
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · 19 Shareholdings (19 companies)
29 Jan 2020 as Mylan Healthcare GmbH
Managing Director: Rainer Weiß · Authorized signatory (ppa): Mirko Ische · No longer Managing Director: Mirko Ische · No longer Authorized signatory (ppa) (2)
3 Sept 2019 as Mylan Healthcare GmbH
Word figurative mark: “knoll“
30 Aug 2019 as Mylan Healthcare GmbH
Wordmark: “PYRICOS“
3 Jun 2019 as Mylan Healthcare GmbH
Word figurative mark: “knoll“
14 May 2019 as Mylan Healthcare GmbH
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (4)
11 Apr 2019 as Mylan Healthcare GmbH
Change of headquarters: Mylan Healthcare GmbH · Address
28 Mar 2019 as Mylan Healthcare GmbH
MD: J. B., M. I. · No longer ppa: M. I. · ppa (9) · Change of headquarters: Mylan Healthcare GmbH · Address · Capital: €300,000 · Share­holder agreement · Proxy policy · Corporate Purpose …
27 Mar 2019 as Mylan Healthcare GmbH
Befreiender Konzernabschluss gem. § 291 HGB zum Geschäftsjahr vom 01.01.2017 bis zum 31.12.2017
5 Mar 2019
Original document: “Gesellschaftsvertrag / Satzung / Statut“
20 Dec 2018 as Mylan Healthcare GmbH
Managing Director: Mirko Ische · No longer Managing Director: Ivo D'Angelo
13 Nov 2018 as Mylan Healthcare GmbH
Managing Director: Jozef Belcik, Anthonius Hullenaar
24 Aug 2018 as Mylan Healthcare GmbH
Authorized signatory (ppa): Mirko Ische
16 May 2018 as Mylan Healthcare GmbH
Befreiender Konzernabschluss gem. § 291 HGB zum Geschäftsjahr vom 01.01.2016 bis zum 31.12.2016
26 Apr 2018 as Mylan Healthcare GmbH
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
14 Mar 2018 as Mylan Healthcare GmbH
No longer Authorized signatory (ppa) (4)
29 Dec 2017 as Mylan Healthcare GmbH
Authorized signatory (ppa) (1)
2 Nov 2017
Wordmark: “Mylan dura“
2 Nov 2017
Wordmark: “Mylan dura“
2 Nov 2017
Wordmark: “Mylan dura“
Year 2017 in Dpmam
6 trademark filings: Dicodid, Lazarus, Methiotrans, Synthroid …
18 Oct 2017 as Mylan Healthcare GmbH
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · 2 Shareholdings: BGP Products Operations GmbH, Rottapharm I Madaus GmbH
19 May 2017 as Mylan Healthcare GmbH
Managing Director: Anthonius Hullenaar · No longer Managing Director: Heike Streu · Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (2)
16 Feb 2017 as Mylan Healthcare GmbH
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
22 Aug 2016 as Mylan Healthcare GmbH
Authorized signatory (ppa): Kathrin Rother
1 Apr 2016 as Mylan Healthcare GmbH
No longer Managing Director (3)
17 Mar 2016 as Mylan Healthcare GmbH
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
10 Mar 2016
Wordmark: “Johanniskraut-dura“
10 Feb 2016 as Mylan Healthcare GmbH
Authorized signatory (ppa) (2)
20 Jan 2016 as Mylan Healthcare GmbH
Managing Director: Ivo D'Angelo
13 Jan 2016 as Mylan Healthcare GmbH
Managing Director: Heike Streu
Year 2015 in Dpmam
2 wordmarks: ALFUZOSIN-DURA, Acardura, Air-Haler, Amlodipin dura, Carbadura, Cefpodoxim dura, Contramig S, DURAVITAL, Finadura, Finadura hair, Futuril, Hot Thermo, Jodid dura, Lipimic, Lipomic …
Year 2015 in Dpmam
111 trademark filings: Adipotheke, Aktinor, Aktinorm, Aktisan, Aktival, Anvitoff., Arzon, BAZOTON UNO, BRUFEN, CLIVARODI, Ceferro, Cholestabyl, Clivarin, Coltrinor, Cordichin …
4 Jun 2015 as Mylan Healthcare GmbH
No longer Authorized signatory (ppa) (1)
3 Jun 2015 as Abbott Arzneimittel GmbH
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
9 Apr 2015 as Mylan Healthcare GmbH
Name: Mylan Healthcare GmbH
24 Mar 2015
Original document: “Gesellschaftsvertrag / Satzung / Statut“
19 Mar 2015 as Abbott Arzneimittel GmbH
Authorized signatory (ppa) (4) · Managing Director (2)
19 Mar 2015 via Abbott Laboratories GmbH also 15/05/2014
Shareholder: Abbott Laboratories GmbH
10 Mar 2015 as Abbott Arzneimittel GmbH
No longer Managing Director (4) · No longer Authorized signatory (ppa) (1)
2 Mar 2015 as Abbott Arzneimittel GmbH
No longer Profit Transfer: Abbott Laboratories GmbH
2 Mar 2015
Original document: “Liste der Gesellschafter“
2 Mar 2015
Original document: “Liste der Gesellschafter“
27 Feb 2015
Original document: “Liste der Gesellschafter“
12 Feb 2015
Original document: “Liste der Gesellschafter“
20 Jan 2015 as Abbott Arzneimittel GmbH
Managing Director (1)
15 Jan 2015 as Abbott Arzneimittel GmbH
Profit Transfer: Abbott Laboratories GmbH
17 Nov 2014 as Mylan Healthcare GmbH
Wordmark: “Eli-Ter“
24 Sept 2014 as Abbott Arzneimittel GmbH
Authorized signatory (ppa) (1) · No longer Managing Director (1)
Year 2014 in Dpmam
73 trademark filings: ALFUZOSIN-DURA, Acardura, Air-Haler, Amiodura, Amlodipin dura, Azathiodura, Carbadura, Cefpodoxim dura, Contramig S, DOPADURA, DURA, DURAVITAL, Doxepin dura, Finadura, Finadura …
12 Jun 2014
Wordmark: “BRUFEDOL“
15 Apr 2014 as Abbott Arzneimittel GmbH
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
4 Feb 2014 as Abbott Arzneimittel GmbH
Managing Director (1)
27 Jan 2014
Managing Director (1)
23 Dec 2013 as Abbott Arzneimittel GmbH
Managing Director (1) · No longer Managing Director (1)
23 Dec 2013 as Abbott Arzneimittel GmbH
Managing Director (1) · Profit Transfer: Abbott Laboratories GmbH
Year 2013 in Dpmam
57 trademark filings: ALFUZOSIN-DURA, Acardura, Air-Haler, Amiodura, Amlodipin dura, Azathiodura, Carbadura, DOPADURA, Doxepin dura, Finadura, Flupendura, Hot Thermo, Lipimic, Lipomic, Lorata …
29 Aug 2013 as Abbott Arzneimittel GmbH
No longer Managing Director (1)
19 Aug 2013
No longer Managing Director (1)
31 Jul 2013 as Abbott Arzneimittel GmbH
Annual report for the year ending 31/12/2011
Year 2013 in Dpmam
31 trademark filings: Cholestabyl, Coltrinor, FULCRO, Fenomic, HOLphar, LIPANTHYL, Lipidil Ter, Lipidil-Ter, Lipimic, Lipomic, Mikrofenat, PYRICOS, VENCELOS …
12 Mar 2013 as Abbott Arzneimittel GmbH
Managing Director (1) · No longer Managing Director (1)
29 Jan 2013 as Abbott Arzneimittel GmbH
No longer Authorized signatory (ppa) (1)
Year 2012 in Dpmam
1 wordmark: Contramig S, DURA, Jodid dura, Lipimic, Lipomic, Metformin dura, Ranidura, Sumig, Tersil, durazepam, penicillin V dura …
13 Dec 2012 as Abbott Arzneimittel GmbH
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
5 Dec 2012 via AbbVie Pharmaceuticals GmbH also 30/08/2011, 04/11/2010
Shareholder: Abbott Products GmbH
2 Oct 2012 as Abbott Arzneimittel GmbH
No longer Profit Transfer: Abbott Products GmbH (bei Abschluss firmierend unter Kali-Chemie Pharma GmbH)
1 Sept 2012
Original document: “Liste der Gesellschafter“
14 Aug 2012 as Abbott Arzneimittel GmbH
Profit Transfer: Abbott Products GmbH (bei Abschluss firmierend als Kali-Chemie Pharma GmbH)
10 Jul 2012 as Abbott Arzneimittel GmbH
Address
10 Jul 2012 as Abbott Arzneimittel GmbH
Address
8 May 2012 as Abbott Arzneimittel GmbH
Managing Director (1) · No longer Managing Director (1) · No longer Authorized signatory (ppa) (1)
25 Apr 2012
Original document: “Liste der Gesellschafter“
Year 2012 in Dpmam
13 trademark filings: Cholestabyl, Coltrinor, FULCRO, Fenomic, HOLphar, LIPANTHYL, Lipidil Ter, Lipidil-Ter, Lipimic, Lipomic, Mikrofenat, PYRICOS, VENCELOS
7 Feb 2012 as Abbott Arzneimittel GmbH
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
14 Sept 2011 as Abbott Arzneimittel GmbH
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (2)
Year 2011 in Dpmam
3 wordmarks: Cefpodoxim dura, Malarex, Silvette, duraviril, mesalazin dura, trimidura
1 Dec 2010 as Abbott Arzneimittel GmbH
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
Year 2010 in Dpmam
4 wordmarks: ALFUZOSIN-DURA, Acardura, Air-Haler, Amiodura, Amlodipin dura, Azathiodura, Carbadura, Cefpodoxim dura, Contramig S, DOPADURA, DURA, DURAVITAL, Doxepin dura, Finadura, Finadura hair …
27 Sept 2010 as Abbott Arzneimittel GmbH
Managing Director (1)
27 Sept 2010 as Abbott Arzneimittel GmbH
Authorized signatory (ppa) (1)
30 Aug 2010
Wordmark: “ZELIUM“
15 Jun 2010 as Mylan Healthcare GmbH
Wordmark: “Eli-Ter“
1 Apr 2010 as Abbott Arzneimittel GmbH
Managing Director (3) · Address · Share­holder agreement · Name: Abbott Arzneimittel GmbH
24 Mar 2010 as Abbott Arzneimittel GmbH
Managing Director (3) · Address · Share­holder agreement · Name: Abbott Arzneimittel GmbH · Proxy policy
16 Feb 2010
Original document: “Gesellschaftsvertrag / Satzung / Statut“
18 Dec 2009 as Solvay Arzneimittel GmbH
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
Year 2009 in Dpmam
5 wordmarks: Finadura hair, Lisette, Lynette, Sodac Mylan, Sodac dura, dopadura B
9 Sept 2009 as Solvay Arzneimittel GmbH
Annual report for the year ending 31/12/2007
3 Aug 2009
Wordmark: “KILOWATCH“
23 Mar 2009 as Solvay Arzneimittel GmbH
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
Year 2008 in Dpmam
3 wordmarks: ALFUZOSIN-DURA, Acardura, Air-Haler, Amiodura, Amlodipin dura, Azathiodura, Carbadura, Cefpodoxim dura, Contramig S, DOPADURA, DURA, DURAVITAL, Doxepin dura, Finadura, Flupendura …
28 Jul 2008 as Solvay Arzneimittel GmbH
Share­holder agreement · Proxy policy
14 Jul 2008
Original document: “Gesellschaftsvertrag / Satzung / Statut“
5 Jun 2008 as Solvay Arzneimittel GmbH
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Shareholding: Solvay Pharma kft
Year 2008 in Euipotm
6 wordmarks: BRUFEN, CLIVARIN, CLIVARINE, FROBEN, GOPTEN, ISOPTIN
Year 2007 in Dpmam
61 trademark filings (1 wordmark, 1 other mark): ALFUZOSIN-DURA, Acardura, Air-Haler, Amiodura, Amlodipin dura, Azathiodura, Carbadura, Cefpodoxim dura, Contramig S, DOPADURA, Doxepin dura, Finadura …
7 Nov 2007 as Mylan Healthcare GmbH
Word figurative mark: “Deutsche Adipositas Stiftung“
17 May 2006
Wordmark: “DOPADURA“
5 Apr 2006
Patent: Method for obtaining primary culture tumor cells FROM tumor tissue, in particular mammary carcinoma, primary culture tumor cells and their use
16 Mar 2006
Wordmark: “ALFUZOSIN-DURA“
22 Feb 2006
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
20 Feb 2006 as Solvay Arzneimittel GmbH
Reg­is­tra­tion · Authorized signatory (ppa) (3) · Managing Director (1) · Capital: €300,000 · Seat: Hanover, Germany · Legal form: GmbH · Name: Solvay Arzneimittel GmbH · Corporate Purpose
Year 2005 in Dpmam
5 wordmarks: Acardura, Air-Haler, Finadura, Metodura ZNT, Soft-Haler, Trimobact
There are no publications matching your search.

Mentions

29 Aug 2025 in Hrcdd also 31/07/2025
Merger: Mylan dura GmbH
17 Jul 2025 in Hrdk
Mylan dura GmbH: “Liste der Gesellschafter“
10 Oct 2023 in Hrdk also 05/10/2023, 04/01/2017, 28/12/2016
ROTTAPHARM I MADAUS GmbH: “Liste der Gesellschafter“
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.